期刊文献+

医学实验室血清球蛋白不确定度评定 被引量:2

Evaluation of measurement uncertainty of serum globulin in medical laboratory
下载PDF
导出
摘要 目的以医学实验室血清球蛋白为例,研究如何用top-down法评定测量不确定度,为临床决策提供一定依据。方法应用top-down法评定不确定度,先评定出有证参考物质(CRM)总蛋白(TP)和白蛋白(Alb)的不确定度,再把这两项的不确定度合成,即为球蛋白(Glb)不确定度。结果浓度为70.10 g/L的TP、37.2 g/L的Alb的相对合成不确定度分别为1.77%、1.83%。Glb相对合成不确定度为2.55%,相对扩展不确定度为5.10%(k=2)。结论用top-down法评定Glb不确定度具有可行性,其可判断患者两次测量结果是否具有统计学差异,对患者的临床诊断和治疗具有潜在指导作用。 Objective To study how to use the top-down method to evaluate the measurement uncertainty based on the seroglobulin in medical laboratories in order to provide certain reference for clinical decision making. Methods The top-down method was used to evaluate the uncertainty, which included evaluating the uncertainties of certified reference materials(CRM) such as total protein(TP) and albumin(Alb) at first and then combining the two uncertainties to get the uncertainty of globulin(Glb). Results The relative combined uncertainties of 70.10 g/L of TP and 37.2 g/L of Alb were 1.77% and 1.83% respectively. The relative combined uncertainty of Glb was 2.55% and its relative expanded uncertainty was 5.10%(k=2). Conclusion The application of the top-down method in evaluating Glb uncertainty is feasible, can determine if there exists statistical difference between patient's two measurements, and it is of potential guiding effect on the clinical diagnosis and treatment for patients.
出处 《中国现代医生》 2015年第27期8-11,15,共5页 China Modern Doctor
基金 江苏省南通市科技项目(HS2012009) 国家质检总局公益性行业科研专项经费项目(201210066)
关键词 测量不确定度 血清球蛋白 偏移 期间不精密度 Measurement uncertainty Serum globulin Bias Intermediate imprecision
  • 相关文献

参考文献20

  • 1JCGM.International vocabulary of basic and general terms in metrology(VIM)[S].3rd.2012.
  • 2ISO/CASCO Committee on Conformity Assessment.Gener- al requirements for the competence of testing and calibra- tion Iaboratories[J].ISO/IEC 17025:2005.
  • 3Guzel O,Guner EI.ISO 15189 Accreditation:Require- ments for quality and competence of medical laboratorie,experience of a laboratory I[J].Clinical Biochemistry,2009,42(4):274-278.
  • 4CNAS-CL01检测和校准实验室能力认可准则[S].2006.
  • 5中国合格评定国家认可委员会.医学实验室质量和能力认可准则[S].北京:CNAS-CL02,2008.
  • 6ISO.In vitro diagnostic medical devices-Measurement of quantities in samples of biological origin-Requirements for content and presentation of reference measurement procedures.ISO 15193.Geneva,Switzerland:ISO,2009.
  • 7ISO.In vitro diagnostic medical devices-Measurement of quantities in samples of biological origin-Requirements for certified reference materials and the content of supporting documentation.ISO 15194.Geneva,SwitzerlandrISO,2009.
  • 8杨振华.关注测量不确定度在临床检验中的应用[J].中华检验医学杂志,2007,30(9):965-966. 被引量:14
  • 9傅新民,洪定玲.血清球蛋白改变对慢性重型肝炎预后的判断价值[J].世界感染杂志,2004,4(5):471-473. 被引量:1
  • 10谢秋里,王功遂,刘梅华.白蛋白、球蛋白、白/球比值与肝组织病理的关系[J].现代医药卫生,2005,21(13):1638-1639. 被引量:15

二级参考文献3

共引文献50

同被引文献18

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部